In memory
What Lou Reed's Story Can Help Us Understand About Liver Cancer
The rock pioneer developed liver cancer and died in 2013. Here is what that diagnosis means, explained calmly and simply.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
On screen and in the news
Lou Reed, the influential songwriter and guitarist known for his work with The Velvet Underground and his long solo career, developed liver disease and liver cancer and underwent a liver transplant in 2013. He died later that year, in October 2013, at age 71. His illness became widely known around the time of his transplant and his death.
That is what was publicly shared. We share it with respect and do not speculate about any private details of his diagnosis or care.
The reality
According to the National Cancer Institute, cancer that starts in the liver is called primary liver cancer. In adults, the most common type of primary liver cancer is hepatocellular carcinoma (HCC). NCI notes that this type is the third leading cause of cancer-related deaths worldwide.
The liver is a large organ in the upper abdomen with many jobs, including helping the body break down food and filter the blood. NCI's resources explain that primary liver cancer can occur in both adults and children, and that treatment for children differs from treatment for adults. A care team uses staging to understand a cancer and to discuss options.
What the story gets right — and what to remember
Public accounts describe a serious illness and a transplant, and it is right to treat that story with care rather than detail. Every person's diagnosis and circumstances are different, and a public figure's experience is not medical advice or a prediction for anyone else. We only ever know what someone, or their family, chooses to share.
Awareness, screening & prevention
NCI has information on liver cancer causes and risk factors, and notes that certain medical tests are used to screen for liver cancer — though not all screening tests are helpful, and many have risks. People with a strong family history or certain chronic liver conditions may have a different conversation with their care team about risk and monitoring. Bringing persistent, unexplained symptoms to a healthcare professional is a sensible step at any age.
Turning a story into something useful
Remembering someone through learning is a gentle way to honor their story. Understanding what liver cancer is, learning what staging means, and knowing that support is a real part of care are calm, useful takeaways. Supporting free, trustworthy cancer education helps make that information available to others facing hard news.
Questions to ask a healthcare team
- What type of liver cancer is being discussed, and what does its stage mean?
- Given my personal or family history, is a conversation about liver cancer risk or monitoring worthwhile?
- What are the goals of the options you are describing?
- What emotional and practical support is available for me and my family?